By Matt Grossman
Thermo Fisher Scientific Inc. has received an emergency-use authorization from the U.S. Food and Drug Administration to perform Covid-19 testing on saliva samples collected with its Spectrum Solutions SpectrumDNA SDNA-1000 device, the company said Monday.
The device can allow laboratories to process 8,000 samples in a day, Thermo Fisher said. The company's senior medical director for genetic testing, Manoj Gandhi, said the authorization could help labs meet high demand.
Write to Matt Grossman at firstname.lastname@example.org
(END) Dow Jones Newswires
October 18, 2021 08:33 ET (12:33 GMT)Copyright (c) 2021 Dow Jones & Company, Inc.